Vanda Pharmaceuticals | VNDA - Lngresos Netos





Lngresos Netos Cambio Fecha
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -13.24M 150.32M 2026-06
J&J USD 5.53B 299M 2026-06
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
Merck USD -1.34B 2.9B 2026-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -1.34B 517M 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD -248M 2.94B 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 343M 1.27B 2026-06
Takeda JPY 113.2B 137.52B 2026-06
Teva Pharmaceutical Industries USD -576M 945M 2026-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Veracyte USD 25.49M 3.22M 2026-06